Holdings of State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
SPDR SERIES TRUST · Original filing · Compare with another fund · Report an error
- Net assets
- 307.9M $ including 307.6M $ in equities, 99.9 %
- Positions
- 59 in 4 countries
- Top ten
- 20.9 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Enliven Therapeutics Inc | 192,297 | 7.5M $ | 2.45 % |
| 2 | Corcept Therapeutics Inc | 174,971 | 7.1M $ | 2.29 % |
| 3 | Terns Pharmaceuticals Inc | 126,197 | 6.7M $ | 2.16 % |
| 4 | Perrigo Co PLC | 601,785 | 6.5M $ | 2.10 % |
| 5 | Axsome Therapeutics Inc | 37,013 | 6.3M $ | 2.03 % |
| 6 | Innoviva Inc | 263,314 | 6.1M $ | 1.99 % |
| 7 | Merck & Co Inc | 50,800 | 6.1M $ | 1.98 % |
| 8 | Pfizer Inc | 216,247 | 6.1M $ | 1.97 % |
| 9 | Royalty Pharma PLC | 126,441 | 6.1M $ | 1.97 % |
| 10 | Elanco Animal Health Inc | 251,749 | 6M $ | 1.96 % |
| 11 | Jazz Pharmaceuticals PLC | 31,838 | 6M $ | 1.96 % |
| 12 | Esperion Therapeutics Inc | 2,194,800 | 6M $ | 1.95 % |
| 13 | Edgewise Therapeutics Inc | 190,497 | 6M $ | 1.95 % |
| 14 | MBX Biosciences Inc | 200,744 | 6M $ | 1.95 % |
| 15 | Definium Therapeutics Inc | 316,882 | 6M $ | 1.95 % |
| 16 | Bristol-Myers Squibb Co | 98,425 | 6M $ | 1.94 % |
| 17 | ANI Pharmaceuticals Inc | 77,382 | 6M $ | 1.93 % |
| 18 | Johnson & Johnson | 24,295 | 5.9M $ | 1.93 % |
| 19 | Tarsus Pharmaceuticals Inc | 84,481 | 5.9M $ | 1.93 % |
| 20 | Trevi Therapeutics Inc | 494,432 | 5.9M $ | 1.92 % |
| 21 | Pacira BioSciences Inc | 258,586 | 5.8M $ | 1.90 % |
| 22 | Zoetis Inc | 49,282 | 5.8M $ | 1.89 % |
| 23 | Crinetics Pharmaceuticals Inc | 159,642 | 5.8M $ | 1.88 % |
| 24 | Nektar Therapeutics | 80,506 | 5.8M $ | 1.88 % |
| 25 | Liquidia Corp | 153,099 | 5.8M $ | 1.88 % |
| 26 | Amneal Pharmaceuticals Inc | 464,477 | 5.8M $ | 1.88 % |
| 27 | Harmony Biosciences Holdings Inc | 205,054 | 5.7M $ | 1.87 % |
| 28 | Supernus Pharmaceuticals Inc | 110,926 | 5.7M $ | 1.86 % |
| 29 | Viatris Inc | 422,585 | 5.7M $ | 1.85 % |
| 30 | Xeris Biopharma Holdings Inc | 975,649 | 5.7M $ | 1.84 % |
| 31 | Harrow Inc | 159,813 | 5.6M $ | 1.83 % |
| 32 | Organon & Co | 922,423 | 5.5M $ | 1.79 % |
| 33 | Nuvation Bio Inc | 1,286,168 | 5.5M $ | 1.79 % |
| 34 | Phibro Animal Health Corp | 99,625 | 5.5M $ | 1.79 % |
| 35 | Amylyx Pharmaceuticals Inc | 395,413 | 5.5M $ | 1.79 % |
| 36 | Indivior Pharmaceuticals Inc | 179,821 | 5.5M $ | 1.78 % |
| 37 | Collegium Pharmaceutical Inc | 165,736 | 5.5M $ | 1.78 % |
| 38 | Eli Lilly & Co | 5,904 | 5.4M $ | 1.76 % |
| 39 | Prestige Consumer Healthcare Inc | 91,089 | 5.4M $ | 1.75 % |
| 40 | Ligand Pharmaceuticals Inc | 26,684 | 5.3M $ | 1.73 % |
| 41 | Ocular Therapeutix Inc | 621,423 | 5.3M $ | 1.71 % |
| 42 | Omeros Corp | 494,846 | 5.2M $ | 1.70 % |
| 43 | EyePoint Inc | 395,677 | 5.1M $ | 1.66 % |
| 44 | Alumis Inc | 224,127 | 4.9M $ | 1.60 % |
| 45 | Amphastar Pharmaceuticals Inc | 227,681 | 4.5M $ | 1.45 % |
| 46 | Phathom Pharmaceuticals Inc | 398,901 | 4.4M $ | 1.44 % |
| 47 | Theravance Biopharma Inc | 268,815 | 4.4M $ | 1.42 % |
| 48 | Rapport Therapeutics Inc | 134,504 | 4.2M $ | 1.37 % |
| 49 | Arvinas Inc | 362,073 | 3.8M $ | 1.25 % |
| 50 | CorMedix Inc | 554,307 | 3.8M $ | 1.22 % |
| 51 | BioAge Labs Inc | 210,974 | 3.7M $ | 1.20 % |
| 52 | Maze Therapeutics Inc | 117,041 | 3.5M $ | 1.13 % |
| 53 | Septerna Inc | 128,633 | 3.1M $ | 1.00 % |
| 54 | WaVe Life Sciences Ltd | 419,283 | 3M $ | 0.99 % |
| 55 | Zevra Therapeutics Inc | 324,871 | 3M $ | 0.98 % |
| 56 | Fulcrum Therapeutics Inc | 367,717 | 2.8M $ | 0.92 % |
| 57 | Aquestive Therapeutics Inc | 600,305 | 2.5M $ | 0.81 % |
| 58 | LB Pharmaceuticals Inc | 89,202 | 2.2M $ | 0.71 % |
| 59 | Alto Neuroscience Inc | 73,288 | 1.6M $ | 0.54 % |
Sector breakdown
- Health care 15.3 %
- Unattributed 84.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 93.0 %
- Ireland 4.1 %
- Canada 1.9 %
- Singapore 1.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 55 | 286.1M $ | 93.01 % |
| 2 | Ireland | 2 | 12.5M $ | 4.06 % |
| 3 | Canada | 1 | 6M $ | 1.95 % |
| 4 | Singapore | 1 | 3M $ | 0.99 % |
Cite this page
Titelia. "Holdings of State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF". https://titelia.com/en/funds/S000012321